156 related articles for article (PubMed ID: 25045365)
1. Kikuchi-Fujimoto disease mimicking malignant lymphoma with 2-[(18)F]fluoro-2-deoxy-D-glucose PET/CT in children.
Kim JE; Lee EK; Lee JM; Bae SH; Choi KH; Lee YH; Hah JO; Choi JH; Kong EJ; Cho IH
Korean J Pediatr; 2014 May; 57(5):226-31. PubMed ID: 25045365
[TBL] [Abstract][Full Text] [Related]
2. Positron emission tomography/computed tomography hypermetabolism of Kikuchi-Fujimoto disease mimicking malignant lymphoma: a case report and literature review.
Wang S; Du B; Li X; Li Y
J Int Med Res; 2021 Jul; 49(7):3000605211032859. PubMed ID: 34334002
[TBL] [Abstract][Full Text] [Related]
3. Kikuchi-Fujimoto Disease with 18F-Fludeoxyglucose Uptake in Cervical Lymph Nodes on Dual-time-point Imaging Positron Emission Tomography/Computed Tomography Mimicking Malignant Disease.
Aoyama KI; Otsuru M; Uchibori M; Ota Y
World J Nucl Med; 2017; 16(1):68-70. PubMed ID: 28217024
[TBL] [Abstract][Full Text] [Related]
4. (18)F-Fluorodeoxyglucose positron emission tomography/computed tomography in patients with Kikuchi-Fujimoto disease: a nine-case series in China.
Zhang J; Dong MJ; Liu KF; Xu LM; Zhao K; Yang J; Weng WW; Qiu H; Lin LL; Zhu YJ
Int J Clin Exp Med; 2015; 8(11):21034-43. PubMed ID: 26885034
[TBL] [Abstract][Full Text] [Related]
5. Splenic uptake on FDG PET/CT correlates with Kikuchi-Fujimoto disease severity.
Seong H; Jeong YH; Lee WJ; Kim JH; Kim JH; Ahn JY; Jeong SJ; Choi JY; Park YS; Yeom JS; Song YG; Cho A; Ku NS
Sci Rep; 2021 May; 11(1):10836. PubMed ID: 34035381
[TBL] [Abstract][Full Text] [Related]
6. Atypical Kikuchi-Fujimoto Disease: FDG-PET Contribution To The Diagnosis.
Kurihara M; Yanagita Y; Yokokawa D; Li Y; Ikusaka M
Eur J Case Rep Intern Med; 2024; 11(2):004258. PubMed ID: 38352805
[TBL] [Abstract][Full Text] [Related]
7. Kikuchi-Fujimoto disease: PET/CT assessment of a rare cause of cervical lymphadenopathy.
Tsujikawa T; Tsuchida T; Imamura Y; Kobayashi M; Asahi S; Shimizu K; Tsuji K; Okazawa H; Kimura H
Clin Nucl Med; 2011 Aug; 36(8):661-4. PubMed ID: 21716016
[TBL] [Abstract][Full Text] [Related]
8. Kikuchi-Fujimoto disease as a rare cause of benign lymphadenopathy and (18)F-FDG PET/CT findings.
Erhamamci S; Reyhan M; Kocer NE
Hell J Nucl Med; 2014; 17(1):41-4. PubMed ID: 24563878
[TBL] [Abstract][Full Text] [Related]
9. Differentiation between malignant and benign pathologic fractures with F-18-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography.
Shin DS; Shon OJ; Byun SJ; Choi JH; Chun KA; Cho IH
Skeletal Radiol; 2008 May; 37(5):415-21. PubMed ID: 18309481
[TBL] [Abstract][Full Text] [Related]
10. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
11. The prevalence and clinical significance of (18) F-2-fluoro-2-deoxy-D-glucose (FDG) uptake in the thyroid gland on PET or PET-CT in patients with lymphoma.
Lin M; Wong C; Lin P; Shon IH; Cuganesan R; Som S
Hematol Oncol; 2011 Jun; 29(2):67-74. PubMed ID: 20635328
[TBL] [Abstract][Full Text] [Related]
12. (18)F-FDG and (18)F-FLT PET/CT imaging in the characterization of mediastinal lymph nodes.
Rayamajhi SJ; Mittal BR; Maturu VN; Agarwal R; Bal A; Dey P; Shukla J; Gupta D
Ann Nucl Med; 2016 Apr; 30(3):207-16. PubMed ID: 26661845
[TBL] [Abstract][Full Text] [Related]
13. Systemic Lupus Erythematosus Associated Pitfalls on
Makis W; Ciarallo A; Gonzalez-Verdecia M; Probst S
Nucl Med Mol Imaging; 2018 Feb; 52(1):74-79. PubMed ID: 29391916
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of
Öner AO; Sürer Budak E; Aydın F; Salim O; Yücel OK; Akkaya B; Toptaş T; Boz A; Yıldız A; Güngör F; Undar L
Mol Imaging Radionucl Ther; 2017 Jun; 26(2):69-75. PubMed ID: 28613199
[TBL] [Abstract][Full Text] [Related]
15. Utilization of 18F-FDG PET/CT as a staging tool in patients with newly diagnosed lymphoma.
Cho SF; Chang CC; Liu YC; Chang CS; Hsiao HH; Liu TC; Huang CT; Lin SF
Kaohsiung J Med Sci; 2015 Mar; 31(3):130-7. PubMed ID: 25744235
[TBL] [Abstract][Full Text] [Related]
16. [Value of Pretherapeutic
Ding CY; Liu HY; Guo Z; Li TN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):438-443. PubMed ID: 28446289
[TBL] [Abstract][Full Text] [Related]
17. Merkel cell carcinoma: Is there a role for 2-deoxy-2-[f-18]fluoro-D-glucose-positron emission tomography/computed tomography?
Iagaru A; Quon A; McDougall IR; Gambhir SS
Mol Imaging Biol; 2006; 8(4):212-7. PubMed ID: 16724293
[TBL] [Abstract][Full Text] [Related]
18. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma.
Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM
Am J Hematol; 2014 Jul; 89(7):726-31. PubMed ID: 24711255
[TBL] [Abstract][Full Text] [Related]
20. Impact of maximum standardized uptake value (SUVmax) evaluated by 18-Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (18F-FDG-PET/CT) on survival for patients with advanced renal cell carcinoma: a preliminary report.
Namura K; Minamimoto R; Yao M; Makiyama K; Murakami T; Sano F; Hayashi N; Tateishi U; Ishigaki H; Kishida T; Miura T; Kobayashi K; Noguchi S; Inoue T; Kubota Y; Nakaigawa N
BMC Cancer; 2010 Dec; 10():667. PubMed ID: 21129184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
